Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-18-010304

Chief Executive Officer acquired 13,513 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Carpenter George C IV Chief Executive Officer 2018-09-28 Grant or award +13,513 $1.85 $24,999 98,806 D
Derivatives
Carpenter George C IV Chief Executive Officer 2018-09-28 Grant or award · Common Stock Purchase Warrant +13,513 13,513 D
Loading xslF345X03/s113039_form4.xml…